Loading...
Escalon Medical Corp.
ESMC•PNK
Healthcare
Medical - Devices
$0.34
$0.02(4.62%)
Escalon Medical Corp. (ESMC) Financial Performance & Income Statement Overview
Review Escalon Medical Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.63%
↓ 1.63%
Operating Income Growth
-121.83%
↓ 121.83%
Net Income Growth
-127.42%
↓ 127.42%
Operating Cash Flow Growth
-285.38%
↓ 285.38%
Operating Margin
4.97%
↑ 4.97%
Gross Margin
45.25%
↑ 45.25%
Net Profit Margin
4.79%
↑ 4.79%
ROE
0.11%
↑ 0.11%
ROIC
0.02%
↑ 0.02%
Escalon Medical Corp. (ESMC) Income Statement & Financial Overview
Review Escalon Medical Corp.'s (ESMC) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $3.22M | $2.78M | $3.47M | $2.70M |
| Cost of Revenue | $1.65M | $1.57M | $2.00M | $1.58M |
| Gross Profit | $1.57M | $1.21M | $1.47M | $1.12M |
| Gross Profit Ratio | $0.49 | $0.44 | $0.42 | $0.41 |
| R&D Expenses | $155940.00 | $140859.00 | $172976.00 | $155848.00 |
| SG&A Expenses | $1.16M | $1.10M | $1.16M | $1.12M |
| Operating Expenses | $1.32M | $1.24M | $1.33M | $1.27M |
| Total Costs & Expenses | $2.96M | $2.81M | $3.33M | $2.85M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $4883.00 | $5262.00 | $3897.00 | $5541.00 |
| Depreciation & Amortization | $9852.00 | $10627.00 | $19252.00 | $3583.00 |
| EBITDA | $260756.00 | -$16328.00 | $157555.00 | -$153025.00 |
| EBITDA Ratio | $0.08 | -$0.006 | $0.05 | -$0.06 |
| Operating Income | $255904.00 | -$26955.00 | $138303.00 | -$156610.00 |
| Operating Income Ratio | $0.08 | -$0.010 | $0.04 | -$0.06 |
| Other Income/Expenses (Net) | $245.77M | -$5262.00 | -$3897.00 | -$5541.00 |
| Income Before Tax | $246.02M | -$32217.00 | $134406.00 | -$162149.00 |
| Income Before Tax Ratio | $76.39 | -$0.01 | $0.04 | -$0.06 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$3.00 |
| Net Income | $246021.00 | -$32217.00 | $134406.00 | -$162149.00 |
| Net Income Ratio | $0.08 | -$0.01 | $0.04 | -$0.06 |
| EPS | $33.18 | -$0.004 | $0.02 | -$0.02 |
| Diluted EPS | $17.47 | -$0.004 | $0.02 | -$0.02 |
| Weighted Avg Shares Outstanding | $7.42M | $7.42M | $7.42M | $7.42M |
| Weighted Avg Shares Outstanding (Diluted) | $14.08M | $7.42M | $7.42M | $7.42M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan